Table 3 Contingency table.
From: Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up
EBC 8-IP [pg/mL] | |||||
|---|---|---|---|---|---|
< 5 | 5-20 | > 20 | Total | ||
CR (+) | No of patients | 7 | 2 | 2 | 11 |
% with CR | 63.6 | 18.2 | 18.2 | 100 | |
% with EBC 8-IP level | 50.0 | 10.5 | 28.6 | 27.5 | |
χ2 | p = 0.04 | ||||
CR (-) | No of patients | 7 | 17 | 5 | 29 |
% with CR | 24.1 | 58.6 | 17.2 | 100 | |
% with EBC 8-IP level | 50.0 | 89.5 | 71.4 | 72.5 | |
χ2 | NS | ||||
Total | No of patients | 14 | 19 | 7 | 40 |
% with CR | 35.0 | 47.5 | 17.5 | 100 | |
% with EBC 8-IP level | 100 | 100 | 100 | 100 | |